Clinical Trial Update: Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of rimonabant, with and without a hypocaloric diet, in obese patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Obesity | Phase 3 | Status: COMPLETED